Skip to main content

Gregory Buckley Elected Executive Vice President and a Portfolio Manager of Adams Diversified Equity Fund

BALTIMORE, July 16, 2026 (GLOBE NEWSWIRE) — Adams Diversified Equity Fund, Inc. (NYSE: ADX), one of the nation’s oldest and most respected closed-end funds, today announced that Gregory W. Buckley has been elected Executive Vice President and a Portfolio Manager of the Fund. Mr. Buckley joined Adams Diversified Equity Fund in September 2013 as a senior equity analyst covering the energy and utilities sectors. He was promoted to Vice President-Research of the Fund in April 2019. He is President of Adams Natural Resources Fund, Inc., ADX’s affiliate, since April 2025, and prior to that was Executive Vice President and a Portfolio Manager since April 2023 and Vice President-Research since April 2015. “Greg has proven his ability as a talented analyst and portfolio manager and has exhibited the insight that I believe will make him...

Continue reading

IPG Photonics Announces Binding Offer to Acquire Lumibird Medical, Expanding IPG’s Medical Laser Growth Platform

 Creates a Scaled Medical Laser Platform, Accelerating IPG’s Strategic Expansion in Advanced Solutions Expected to Be Accretive to Gross Margin, EBITDA, and Adjusted EPS MARLBOROUGH, Mass., July 16, 2026 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP) today announced that it has entered into a binding offer to acquire Lumibird Medical. The acquisition advances IPG’s strategy, further expanding the Advanced Solutions portfolio in attractive medical markets. The transaction is expected to deliver financial benefits by adding a high-margin business that is accretive to gross margin, EBITDA and adjusted EPS. IPG believes that the combined medical businesses will create a scaled medical laser platform for growth with complementary established leadership in ophthalmology and urology. The company expects that this also adds...

Continue reading

Constellation Software Inc. Announces Conference Call to Discuss Second Quarter Results

TORONTO, July 16, 2026 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) announced today it will host a second quarter conference call and live audio webcast on August 12, 2026 at 8:00 a.m. ET. The Company’s quarterly results will be disseminated via press release, and made available on the Company’s website (www.csisoftware.com) and SEDAR+ (www.sedarplus.ca), after the Toronto Stock Exchange closes on Tuesday, August 11, 2026. Mark Miller, President, Jamal Baksh, Chief Financial Officer, and Bernard Anzarouth, Chief Investment Officer will be available during the August 12, 2026 conference call to answer questions regarding the Company’s results. To access the call, please dial 1-877-879-1183 (North America toll free) or 1-412-902-6703 (International) and using conference ID 8400862.  A conference operator will create a...

Continue reading

Hammond Power Solutions Announces Second Quarter 2026 Financial Results Conference Call and Webcast Notification

GUELPH, Ontario, July 16, 2026 (GLOBE NEWSWIRE) — Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) today announced that it will release its financial results for the Second Quarter ended June 27, 2026, on Thursday, July 30, 2026, after markets close. Following the release of its financial results, HPS will hold a conference call and webcast on Friday, July 31, 2026, at 9:00 a.m. Eastern Time. This call can be accessed by registration through participant links: Date/Time: July 31, 2026/ 9 a.m. ET Live Call Participant Registration Link:https://register-conf.media-server.com/register/BI36cb466bfca54d899e8213af20211365 Audio-Only Webcast:https://edge.media-server.com/mmc/p/8pcnypga A webcast replay will be available for 12 months. ABOUT HAMMOND POWER SOLUTIONS INC.Hammond Power Solutions Inc. (“HPS” or the “Company”)...

Continue reading

Jasper Therapeutics Announces Merger with Kira Pharmaceuticals

Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven disorders  Concurrent $132 million private investment with participation from leading life sciences investors and Mirador Therapeutics Kira out-licenses KP-301, a long-acting anti-C5a monoclonal antibody, and KP-402, a small molecule C5a receptor antagonist, to Mirador Therapeutics, for $12 million upon signing and potential development and sales milestone payments Combined financing and transactions expected to fund combined company operations through the second half of 2028, including multiple clinical milestones REDWOOD CITY, Calif. and CAMBRIDGE, Mass., July 16, 2026 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper” or the “Company”), today announced that Jasper...

Continue reading

Adams Natural Resources Fund Announces First Half 2026 Performance

BALTIMORE, July 16, 2026 (GLOBE NEWSWIRE) — Adams Natural Resources Fund, Inc. (NYSE: PEO) today announced the Fund’s investment returns for the first half of 2026. The total return on the Fund’s net asset value for the first half of 2026 was 18.4%, with dividends and capital gains reinvested. The comparable figures for the S&P 500 Energy Sector and the S&P 500 Materials Sector were 19.7% and 12.0%, respectively. Our benchmark, which is comprised of the S&P 500 Energy Sector (80%) and the S&P 500 Materials Sector (20%), returned 18.1%. The total return on the Fund’s market price for the same period was 18.2%. The Semi-Annual Report to Shareholders is expected to be released on or about July 22, 2026.ANNUALIZED COMPARATIVE RETURNS (6/30/2026)           1 Year 3 Year 5 Year 10 YearAdams Natural Resources...

Continue reading

UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

Transaction positions the combined company to execute a capital-efficient, repeatable strategy leveraging public market access and Lōkahi Therapeutics ai²-driven asset sourcing, development, and advancement platform RUTHERFORD, N.J. and LA JOLLA, Calif., July 16, 2026 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lōkahi Therapeutics, establishing a publicly listed, capital-efficient platform for the identification, acquisition, and advancement of differentiated healthcare assets. The transaction is structured such that Lōkahi Therapeutics becomes the operating and controlling business of the combined company, leveraging Glucotrack’s public market platform to support long-term growth and access to capital. The combined organization integrates Lōkahi Therapeutics’...

Continue reading

Adams Diversified Equity Fund Announces First Half 2026 Performance

BALTIMORE, July 16, 2026 (GLOBE NEWSWIRE) — Adams Diversified Equity Fund, Inc. (NYSE: ADX) today announced the Fund’s investment returns for the first half of 2026. The total return on the Fund’s net asset value for the first half of 2026 was 10.8%, with dividends and capital gains reinvested. This compared to 10.2% and 9.5% total return for the S&P 500 Index and the Morningstar U.S. Large Blend category, respectively. The total return on the Fund’s market price for the period was 13.9%. The Semi-Annual Report to Shareholders is expected to be released on or about July 22, 2026.ANNUALIZED COMPARATIVE RETURNS (6/30/2026)           1 Year 3 Year 5 Year 10 YearAdams Diversified Equity Fund (NAV) 22.2% 21.5% 14.1% 16.5%Adams Diversified Equity Fund (market price) 27.4% 27.4% 16.9% 18.2%Morningstar U.S. Large...

Continue reading

Tim Lamb Group Represents David Weaver in the Successful Sale of Wheeling Subaru Volkswagen in Wheeling, West Virginia to Crown Auto Group

Crown Auto Group adds its first Subaru and Volkswagen Dealerships while expanding its growing presence across West Virginia and PennsylvaniaWheeling Subaru Volkswagen is sold to Crown Auto GroupFrom Left to Right: Previous Owner of Wheeling Subaru Volkswagen, David Weaver, Director at Tim Lamb Group, Blair Sharpe, Chief Operating Officer of Crown Auto Group, Kolten Saunders, and Attorney Johnnie Brown stand together after the closing of Wheeling Subaru Volkswagen in Wheeling, West Virginia on June 24, 2026.Columbus, OH, July 16, 2026 (GLOBE NEWSWIRE) — Tim Lamb Group, the largest auto dealership sales and acquisitions firm in North America, is pleased to announce the successful sale of Wheeling Subaru Volkswagen, located at 3569 National Road in Wheeling, West Virginia, to Crown Auto Group. The transaction officially...

Continue reading

ARRAY Technologies to Acquire Affordable Wire Management (AWM), Creating New Growth Platform in Balance-of-System Solutions

Strategic acquisition adds high-margin cable management products and extends ARRAY’s reach across utility-scale solar, distributed generation, BESS, and datacenter applicationsAdds a highly complementary, accretive balance-of-system product portfolio spanning solar wire management, cable protection solutions, and battery energy storage solutions (BESS) Creates new growth opportunities in fast-growing adjacencies including BESS and datacenter infrastructure Total Consideration of approximately $203 million represents an attractive multiple of 8.8x AWM’s trailing twelve-month EBITDA Expected to be high single digit accretive to ARRAY’s Adjusted EPS in year one before synergies Closing expected in the third quarter of 2026, subject to regulatory clearance and customary closing conditionsALBUQUERQUE, N.M., July 16, 2026 ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.